You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 11,000,498


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 11,000,498 protect, and when does it expire?

Patent 11,000,498 protects LUMRYZ and is included in one NDA.

This patent has twenty-nine patent family members in ten countries.

Summary for Patent: 11,000,498
Title:Modified release gamma-hydroxybutyrate formulations having improved pharmacokinetics
Abstract:Modified release formulations of gamma-hydroxybutyrate having improved dissolution and pharmacokinetic properties are provided, and therapeutic uses thereof.
Inventor(s):Megret Claire, Guillard Herve, Dubuisson Jean-Francois, Grassot Julien
Assignee:Flamel Ireland Limited
Application Number:US16431219
Patent Claim Types:
see list of patent claims
 
Patent landscape, scope, and claims:

Analyzing the Scope and Claims of United States Patent 11,000,498: A Comprehensive Guide

Introduction

When analyzing a patent, understanding its scope, claims, and the broader patent landscape is crucial for inventors, businesses, and legal professionals. This article will delve into the details of United States Patent 11,000,498, providing a thorough analysis of its claims and the surrounding patent landscape.

Understanding Patent Claims

Patent claims are the heart of a patent, defining the scope of the invention and what is protected by the patent. The claims must be clear, concise, and definite to ensure that the public understands what is patented and what is not[3].

Locating the Patent

To analyze the patent, the first step is to locate it. The United States Patent and Trademark Office (USPTO) provides several tools for this purpose, including the Patent Public Search tool, which replaced older tools like PubEast and PubWest. This tool offers modern interfaces and enhanced access to prior art[1].

Patent Public Search Tool

Using the Patent Public Search tool, you can search for the patent by its number, title, or other relevant keywords. This tool allows you to view the patent document, including its claims, descriptions, and drawings.

Analyzing the Claims of Patent 11,000,498

Claim Structure

Patent claims are typically structured into independent and dependent claims. Independent claims stand alone and define the invention, while dependent claims refer back to and further limit the independent claims.

Claim Language

The language used in the claims is critical. It must be precise and avoid ambiguity to ensure that the scope of the invention is clearly defined. For example, if a claim in Patent 11,000,498 describes a "method for processing data," it would need to specify the steps involved and any particular elements or limitations that distinguish it from prior art.

Claim Scope

The scope of the claims determines what is protected by the patent. This includes the specific features, components, and processes described. For instance, if a claim includes a specific algorithm or a particular type of material, these elements would be part of the protected scope.

Patent Landscape Analysis

Global Dossier

The Global Dossier service provided by the USPTO allows users to view the patent family for a specific application, including related applications filed at participating IP Offices. This can help in understanding how the patent fits into the global patent landscape and identify potential overlaps or conflicts[1].

International Patent Offices

Searching international patent databases, such as those provided by the European Patent Office (EPO), Japan Patent Office (JPO), and World Intellectual Property Organization (WIPO), can reveal whether similar inventions have been patented abroad. This is crucial for determining the global scope of the patent and potential infringement risks[1].

Patent Classification

Patent classification systems, such as the Cooperative Patent Classification (CPC) system, help organize patents into specific technology groupings. Using these classifications can streamline the search process and ensure that relevant patents are identified[4].

Prior Art and Citation Analysis

Common Citation Document (CCD)

The Common Citation Document (CCD) application consolidates prior art citations from participating IP Offices, allowing users to see the prior art cited by multiple offices for the same invention. This helps in understanding the novelty and non-obviousness of the patent claims[1].

Patent Examination Data System (PEDS)

The PEDS system provides access to bibliographic data for patent applications, which can be used to analyze the examination history and prior art citations related to the patent. This data can offer insights into the patent's validity and potential challenges[1].

Legal and Jurisdictional Considerations

Patentability Under Section 101

The patentability of an invention under Section 101 of the Patent Act must be considered. The Supreme Court's "Alice" test is often used to determine if claims are directed to abstract ideas, which are not patentable. The test involves two steps: determining if the claims are directed to an abstract idea, and if so, whether they include elements that transform them into a patent-eligible application[2].

Case Law and Precedents

Recent court decisions, such as those involving digital camera technologies, can provide guidance on how similar claims might be interpreted. For example, the case of Contour IP Holding LLC v. GoPro, Inc. highlights the importance of specific technological means in claims to ensure they are patent-eligible[2].

Practical Applications and Implications

Patent Landscape Reports

Patent landscape reports can provide a comprehensive view of the patent outlook for a given technology or industry. These reports can help businesses and inventors understand the competitive landscape and identify opportunities for innovation[4].

Commercial and Strategic Considerations

Understanding the scope and claims of a patent is essential for commercial and strategic decisions. It helps in assessing the potential for infringement, licensing opportunities, and the development of new products or technologies.

Key Takeaways

  • Precise Claim Language: The language used in patent claims must be clear and specific to define the invention accurately.
  • Global Patent Landscape: Analyzing the global patent landscape through tools like Global Dossier and international patent databases is crucial.
  • Prior Art and Citation Analysis: Tools like CCD and PEDS help in understanding the novelty and non-obviousness of the patent claims.
  • Legal Considerations: Ensuring patentability under Section 101 and considering relevant case law are essential.
  • Practical Applications: Understanding the patent landscape and claims helps in making informed commercial and strategic decisions.

FAQs

Q: How do I search for a specific patent using the USPTO's Patent Public Search tool?

A: You can search for a patent by its number, title, or other relevant keywords using the Patent Public Search tool on the USPTO website.

Q: What is the importance of patent classification in searching for patents?

A: Patent classification helps organize patents into specific technology groupings, making it easier to find relevant patents and save time in the search process.

Q: How does the Global Dossier service help in patent analysis?

A: The Global Dossier service allows users to view the patent family for a specific application, including related applications filed at participating IP Offices, which helps in understanding the global patent landscape.

Q: What is the "Alice" test, and how is it used in patent analysis?

A: The "Alice" test is a two-step test used to determine if patent claims are directed to abstract ideas, which are not patentable. It involves determining if the claims are directed to an abstract idea and if they include elements that transform them into a patent-eligible application.

Q: Why is it important to analyze prior art citations in patent analysis?

A: Analyzing prior art citations helps in understanding the novelty and non-obviousness of the patent claims, which is crucial for determining the patent's validity and potential challenges.

Sources

  1. USPTO - Search for patents: https://www.uspto.gov/patents/search
  2. CONTOUR IP HOLDING LLC v. GOPRO, INC.: https://cafc.uscourts.gov/opinions-orders/22-1654.OPINION.9-9-2024_2381170.pdf
  3. USPTO - Patent Claims Research Dataset: https://www.uspto.gov/ip-policy/economic-research/research-datasets/patent-claims-research-dataset
  4. Brown University Library Guides - Patents: https://libguides.brown.edu/patent

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 11,000,498

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-001 May 1, 2023 RX Yes Yes 11,000,498 ⤷  Subscribe Y TREATMENT OF NARCOLEPSY USING A DOSE PROPORTIONAL, ORAL PHARMACEUTICAL COMPOSITION COMPRISING GAMMA-HYDROXYBUTYRATE ONCE DAILY ⤷  Subscribe
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-002 May 1, 2023 RX Yes No 11,000,498 ⤷  Subscribe Y TREATMENT OF NARCOLEPSY USING A DOSE PROPORTIONAL, ORAL PHARMACEUTICAL COMPOSITION COMPRISING GAMMA-HYDROXYBUTYRATE ONCE DAILY ⤷  Subscribe
Avadel Cns LUMRYZ sodium oxybate FOR SUSPENSION, EXTENDED RELEASE;ORAL 214755-003 May 1, 2023 RX Yes No 11,000,498 ⤷  Subscribe Y TREATMENT OF NARCOLEPSY USING A DOSE PROPORTIONAL, ORAL PHARMACEUTICAL COMPOSITION COMPRISING GAMMA-HYDROXYBUTYRATE ONCE DAILY ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.